Reply SpA (0RV0)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 127.15 |
|---|---|
| 52-week range | 75.39 – 129.90 |
| Return, 1 month / 3 months | +7.1% / +34.2% |
| Return, 1 year / 3 years | +8.8% / +50.3% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 37.8% |
| Worst drawdown (1 year) | -38.3% |
| Average daily value traded | 0.29M EUR |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reply is an Italian information technology company based in Turin. It designs and implements digital solutions, offering consulting, system integration and application management services. Its customers are mainly large companies and public sector organisations that need help with digital transformation projects. Reply works through a group of specialised subsidiaries that focus on different areas of technology and industry, and it serves clients across Europe and beyond.
Reply SpA trades under the code 0RV0 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reply SpA (0RV0) trades on the London Exchange in UK. It last closed at EUR 127.15 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,172 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.8% and over the last three months it rose 34.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.7% | ||
| From 52-week high | -2.1% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 34.2% | ||
| 6-month return | 34.7% | ||
| 12-month return, skipping the last month | 1.6% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.3% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.29M EUR | ||
| Zero-volume days | 5.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | +7.1% |
| 3 months | +34.2% |
| 6 months | +34.7% |
| 1 year | +8.8% |
| 3 years | +50.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 120.57 / 102.76 |
|---|---|
| Golden / death cross (60 days) | Golden, 47 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 1.3500 |
| 19 May 2025 | EUR 1.1500 |
| 20 May 2024 | EUR 1.0000 |
| 22 May 2023 | EUR 1.0000 |
| 23 May 2022 | EUR 0.8000 |
| 3 May 2021 | EUR 0.5600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.